03692.HK
Hansoh Pharmaceutical Group Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 32.36
−2.18%Margins
Gross margin
90.5%
EBITDA margin
39.8%
EBIT margin
37.5%
Net margin
42.0%
FCF margin
38.1%
17.7%
Return on equity
14.3%
Return on assets
14.2%
Return on invested capital
0.37x
Asset turnover
HKD 7.6B
Cash from operations
HKD 7.35
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026